Safety and Tolerability of KH631 Gene Therapy in Participants With Neovascular Age-related Macular Degeneration
Clinical trial NCT05657301 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05657301
- Sponsor
- Chengdu Origen Biotechnology Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-16
- Primary completion
- 2026-09-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.